Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients

With balanced safety-efficacy profile, letermovir anti-cytomegalovirus (CMV) prophylaxis is used in hematopoietic stem cell transplant recipients (HSCTR). We assessed feasibility and usefulness of letermovir therapeutic drug monitoring (TDM) in HSCTR. We performed a prospective observational study o...

Descripción completa

Detalles Bibliográficos
Autores principales: Royston, Léna, Masouridi-Levrat, Stavroula, Gotta, Verena, Royston, Eva, Pressacco-Brossier, Caroline, Abi Aad, Yasmine, Tonoli, David, Karmime, Abderrahim, Jayo, Murielle, Van Delden, Christian, Lescuyer, Pierre, Pfister, Marc, Chalandon, Yves, Neofytos, Dionysios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380536/
https://www.ncbi.nlm.nih.gov/pubmed/35876579
http://dx.doi.org/10.1128/aac.00657-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380536/
https://www.ncbi.nlm.nih.gov/pubmed/35876579
http://dx.doi.org/10.1128/aac.00657-22

Ejemplares similares